NeuroMetrix Announces Participation at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City Septemb...
September 06 2016 - 11:00AM
Business Wire
NeuroMetrix, Inc. (NASDAQ:NURO) today announced it will be
featured as a presenting company at the 18th Annual Rodman &
Renshaw Global Investment Conference, sponsored by H.C. Wainwright
& Co., LLC. The conference is being held on September
11-13, 2016, at Lotte New York Palace Hotel in New York City.
Shai N. Gozani, M.D., Ph.D., President and CEO of NeuroMetrix,
will provide an overview of the Company's business during the live
presentation and will be available to participate in one-on-one
meetings with investors who are registered to attend the
conference.
NeuroMetrix's presentation is scheduled for Monday, September
12, 2016 at 9:10 a.m. Eastern time.
A live audio webcast will be available on the investor relations
section of the corporate website, www.NeuroMetrix.com. This webcast
will be archived after the live event.
About NeuroMetrix
NeuroMetrix is a commercial stage, innovation driven
healthcare company combining bioelectrical and digital medicine to
address chronic health conditions including chronic pain, sleep
disorders and diabetes. The company’s lead product is Quell®, an
over-the-counter wearable therapeutic device for chronic pain.
Quell is integrated into a digital health platform that helps
patients optimize their therapy and decrease the impact of chronic
pain on their quality of life. The company also markets DPNCheck®,
a rapid point-of-care test for diabetic neuropathy, which is the
most common long-term complication of Type 2 diabetes. The company
maintains an active research effort and has several pipeline
programs, including a therapeutic device for restless leg syndrome.
The company is located in Waltham, Massachusetts and was
founded as a spinoff from the Harvard-MIT Division of Health
Sciences and Technology in 1996. For more information, please
visit www.NeuroMetrix.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160906005882/en/
NeuroMetrix, Inc.Thomas T. Higgins, 781-314-2761SVP and Chief
Financial OfficerNeurometrix.ir@neurometrix.com
NeuroMetrix (NASDAQ:NURO)
Historical Stock Chart
From Mar 2024 to Apr 2024
NeuroMetrix (NASDAQ:NURO)
Historical Stock Chart
From Apr 2023 to Apr 2024